Consensus Estimates For Amazon’s First Quarter Of 2021

Amazon.com Inc (NASDAQ: AMZN) will be reporting its first quarter financial results on April 29th after market close. Analysts have a consensus $3,993.18 12-month price target on the company, via a total of 47 analysts, with 18 analysts having strong buy ratings. 27 analysts meanwhile have buy ratings and, two analysts have hold ratings. The street high comes from Susquehanna Financial with a $5,200 price target, and the lowest target sits at $3,048 from R5 Capital.

36 analysts have revenue estimates for the first quarter. The mean revenue estimate between all 36 analysts is $104.46 billion; this number has been revised upwards from $95.31 billion at the start of the year. The highest revenue estimate is $107.5 billion, while the lowest is $99.5 billion.

The analyst consensus for net income for the first quarter is $4.96 billion, this is up from the start of the year which was $4.79 billion. The highest net income estimate is $6.14 billion, while the lowest is $3.3 billion.

Onto EBITDA estimates, there are currently 26 analysts who have first-quarter EBITDA estimates. The mean is currently $15.84 billion, with this number having been revised up from $14.84 billion at the start of the year. The street high estimate currently sits at $18 billion in EBITDA and the lowest is $14.13 billion.

Analysts estimate that quarterly earnings per share will come in at $9.54, with this number being slightly revised up from $9.04 at the start of the year. Street high is $12.00 and the lowest estimate is $6.41 per share for the quarter.


Video Articles

The Grocery Grift: Why Toronto and New York Are About to Light Taxpayer Money on Fire

This Gold Story Starts With Cash Flow | Gordon Robb – ESGold

Silverco Cusi Mine PEA: Bigger Isn’t Always Better

Recommended

Antimony Resources Drills 4.38% Sb Over 7.05 Metres At Bald Hill In Final Hole Of 2025 Program

Kirkland Lake Drills 121 Metres Of 1.01 g/t Gold At Mirado

Related News

GFL Environmental: “Risk/Reward Looking Increasingly Favourable”

Last week, BMO Capital Markets reiterated their 12-month price target of C$39 and Outperform rating...

Monday, July 12, 2021, 03:56:00 PM

Canaccord’s Digital Asset Symposium Sees Michael Saylor Push Bitcoin As A Hedge Against Uncertainty

On February 15th, Canaccord Genuity hosted their fourth consecutive Digital Assets Symposium, which included a...

Sunday, February 27, 2022, 11:14:00 AM

Galaxy Digital: BMO Anticipates Contagion From FTX To Impact Firm

As crypto is facing its own Leman Brothers’ moment, with the third largest exchange stopping...

Sunday, November 13, 2022, 05:27:00 PM

Canaccord Slashes Antibe Therapeutics Price Target A Month After Drug Trial Paused

On August 3, Antibe Therapeutics Inc. (TSX: ATE) announced that they have paused their study...

Wednesday, September 29, 2021, 11:44:00 AM

Vireo Health: Canaccord Lowers Revenue Estimates, Reiterates Price Target

Vireo Health (CSE: VREO) reported its second-quarter financials’ on August 26th, indicating revenue for the...

Thursday, August 27, 2020, 05:30:27 PM